Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
Biochemical Society Transactions
|
January 16, 2010
Drug discovery and assay development in the ubiquitin-proteasome system
Celia R Berkers, Huib Ovaa
Trends in Pharmacological Sciences
|
April 30, 2005
Immunotherapeutic potential for ceramide-based activators of iNKT cells
Celia R Berkers, Huib Ovaa
Frontiers in Oncology
|
November 21, 2018
The Influence of Metabolism on Drug Response in Cancer
Esther A Zaal, Celia R Berkers
Frontiers in Oncology
|
October 2, 2024
Bridging the gap: advancing cancer cell culture to reveal key metabolic targets
Marjolein M G Kes, Celia R Berkers, Jarno Drost
The International Journal of Biochemistry & Cell Biology
|
September 27, 2008
Transpeptidation and reverse proteolysis and their consequences for immunity
Celia R Berkers, Annemieke de Jong, Huib Ovaa, et al.
Structure (London, England : 1993)
|
March 15, 2006
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome
Michael Groll, Celia R Berkers, Hidde L Ploegh, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 1, 2024
Stable Isotope Tracing Experiments Using LC-MS
Esther A Zaal, Jeroen W A Jansen, Celia R Berkers
Methods in Molecular Biology (Clifton, N.J.)
|
November 9, 2011
Fluorescence-based proteasome activity profiling
Annemieke de Jong, Karianne G Schuurman, Boris Rodenko, et al.
Cancer & Metabolism
|
September 1, 2017
Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
Esther A Zaal, Wei Wu, Gerrit Jansen, et al.
Molecular & Cellular Proteomics : MCP
|
April 20, 2018
CTGF/VEGFA-activated Fibroblasts Promote Tumor Migration Through Micro-environmental Modulation
Wei Wu, Esther A Zaal, Celia R Berkers, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
Biochemical Society Transactions
|
January 16, 2010
Drug discovery and assay development in the ubiquitin-proteasome system
Celia R Berkers, Huib Ovaa
Trends in Pharmacological Sciences
|
April 30, 2005
Immunotherapeutic potential for ceramide-based activators of iNKT cells
Celia R Berkers, Huib Ovaa
Frontiers in Oncology
|
November 21, 2018
The Influence of Metabolism on Drug Response in Cancer
Esther A Zaal, Celia R Berkers
Frontiers in Oncology
|
October 2, 2024
Bridging the gap: advancing cancer cell culture to reveal key metabolic targets
Marjolein M G Kes, Celia R Berkers, Jarno Drost
The International Journal of Biochemistry & Cell Biology
|
September 27, 2008
Transpeptidation and reverse proteolysis and their consequences for immunity
Celia R Berkers, Annemieke de Jong, Huib Ovaa, et al.
Structure (London, England : 1993)
|
March 15, 2006
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome
Michael Groll, Celia R Berkers, Hidde L Ploegh, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 1, 2024
Stable Isotope Tracing Experiments Using LC-MS
Esther A Zaal, Jeroen W A Jansen, Celia R Berkers
Methods in Molecular Biology (Clifton, N.J.)
|
November 9, 2011
Fluorescence-based proteasome activity profiling
Annemieke de Jong, Karianne G Schuurman, Boris Rodenko, et al.
Cancer & Metabolism
|
September 1, 2017
Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
Esther A Zaal, Wei Wu, Gerrit Jansen, et al.
Molecular & Cellular Proteomics : MCP
|
April 20, 2018
CTGF/VEGFA-activated Fibroblasts Promote Tumor Migration Through Micro-environmental Modulation
Wei Wu, Esther A Zaal, Celia R Berkers, et al.
Page
of 7